07 November 2023
: Case report
Neoadjuvant Lorlatinib Induces Pathological Complete Response in Advanced ALK-Positive Lung Cancer: A Case Report
Unusual or unexpected effect of treatment, Unexpected drug reaction
Jie Li1E, Junwei Liu2BC, Guqin Zhang3B, Weidong Hu2G, Xianguo Wang2B*, Jun Liu2ADOI: 10.12659/AJCR.942150
Am J Case Rep 2023; 24:e942150
Figure 4. Schematic of timeline with therapy and disease status.






